ACIU CIK: 1651625

AC Immune SA

  • Switzerland
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions CHF
FY21:
203
FY22:
128
FY23:
125
FY24:
172
FY25:
96.7
(positive)
Change from FY21 to FY25
millions CHF
FY21:
58.8
FY22:
57.8
FY23:
57.7
FY24:
58.9
FY25:
57.5
Total assets
Change from FY21 to FY25
millions CHF
FY21:
261
FY22:
186
FY23:
183
FY24:
231
FY25:
154

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions CHF
FY21:
20.0
FY22:
11.5
FY23:
13.6
FY24:
101
FY25:
94.7
(negative)
Change from FY21 to FY25
millions CHF
FY21:
9.44
FY22:
5.47
FY23:
8.60
FY24:
17.8
FY25:
14.7
(positive)
Change from FY21 to FY25
millions CHF
FY21:
232
FY22:
169
FY23:
161
FY24:
112
FY25:
44.9
Total liabilities & equity
Change from FY21 to FY25
millions CHF
FY21:
261
FY22:
186
FY23:
183
FY24:
231
FY25:
154

All amounts in millions CHF Data sources:SEC EDGARTwelve Data